Decision: Favourable

Study Title:

CONNected Electronic Inhalers Asthma Control Trial 3 (“CONNECT 3”), a 24-Week Treatment, Multicenter, Open-Label, Randomized, Parallel Group Comparison Study of Standard of Care Treatment Versus the Budesonide/Formoterol Digihaler Digital System, to Optimize Outcomes in Adult Patients with Asthma

  • NREC Code:

    22-NREC-CT-133

  • Decision:

    Favourable

  • Meeting Date:

    17/08/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Prof Richard Costello

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Teva Branded Pharmaceutical

Scroll to Top